Pioglitazone could induce remission in major depression: a meta-analysis

BACKGROUND: Pioglitazone, a selective agonist of the nuclear transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-γ), prescribed for the treatment of type 2 diabetes, could have antidepressant properties. However, its potential to induce remission of major depressive episodes,...

Descripción completa

Detalles Bibliográficos
Autores principales: Colle, Romain, de Larminat, Delphine, Rotenberg, Samuel, Hozer, Franz, Hardy, Patrick, Verstuyft, Céline, Fève, Bruno, Corruble, Emmanuelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182046/
https://www.ncbi.nlm.nih.gov/pubmed/28031713
http://dx.doi.org/10.2147/NDT.S121149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182046/
https://www.ncbi.nlm.nih.gov/pubmed/28031713
http://dx.doi.org/10.2147/NDT.S121149

Ejemplares similares